Longevity Technology Transfer: From Laboratory to Marketplace
Preprint
- 16 May 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The leap from laboratory to marketplace represents the critical chasm in longevity technology innovation. While scientific breakthroughs in aging biology continue to accelerate (López-Otín et al., 2023; DePinho et al., 2024), the commercialization pathway remains fragmented, creating a unique "valley of death" where promising discoveries often fail to reach consumers despite substantial investment interest (Campisi et al., 2019). At stake is a projected $46.62 billion market by 2033 (Business Research Insights, 2024) that could revolutionize healthcare by shifting from disease treatment to prevention of aging itself—potentially the most transformative healthcare paradigm since antibiotics (Deloitte, 2024). The implications of successful longevity technology commercialization extend far beyond the healthcare sector, as increased lifespans would necessitate dramatic changes in workforce participation to compensate for declining new entrants to the labor force (Papapetrou & Tsalaporta, 2020), restructuring of pension and insurance systems that collectively manage trillions of dollars (Amaglobeli et al., 2019), and fundamental adjustments to social structures across developed economies (Grand View Research, 2024).Keywords
All Related Versions
This publication has 14 references indexed in Scilit:
- The quest to slow ageing through drug discoveryNature Reviews Drug Discovery, 2020
- From discoveries in ageing research to therapeutics for healthy ageingNature, 2019
- Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot studyEBioMedicine, 2019
- Aging as a Biological Target for Prevention and TherapyJAMA, 2018
- DNA methylation-based biomarkers and the epigenetic clock theory of ageingNature Reviews Genetics, 2018
- Balancing Safety and Innovation for Cell-Based Regenerative MedicineNew England Journal of Medicine, 2018
- Strategies and Challenges in Clinical Trials Targeting Human AgingThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2016
- Metformin as a Tool to Target AgingCell Metabolism, 2016
- Drugs that modulate aging: the promising yet difficult path aheadTranslational Research, 2014
- University entrepreneurship: a taxonomy of the literatureIndustrial and Corporate Change, 2007